Related Experiment Video

Updated: Jul 4, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
09:12

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

5-Chloroacetyl-2-amino-1,3-selenazoles attenuate microglial inflammatory responses through NF-kappaB inhibition

Kyong Nyon Nam1, Mamoru Koketsu, Eunjoo H Lee

  • 1Department of Medical Science, Graduate School of East-West Medical Science, Kyung Hee University, Yongin-Si, Republic of Korea.

European Journal of Pharmacology
|June 10, 2008
PubMed

Insights

New selenium compounds, CS1 and CS2, effectively reduce inflammation in activated microglia. These compounds show potential for neuroprotection in neurological diseases by inhibiting key inflammatory pathways.

Area of Science:

  • Neuroscience
  • Immunology
  • Medicinal Chemistry

Background:

  • Microglia are key immune cells in the central nervous system (CNS).
  • Chronic microglial activation releases toxic molecules, endangering neurons and contributing to neurological diseases.
  • Negative regulators of microglial activation are potential therapeutic targets.

Purpose of the Study:

  • To investigate the anti-inflammatory effects of 2-amino-1,3-selenazole derivatives on microglial activation.
  • To identify specific compounds that can inhibit inflammatory responses in microglia.

Main Methods:

  • Tested 26 derivatives of 2-amino-1,3-selenazole and bis-(2-amino-5-selenazoyl) ketones.
  • Assessed inhibition of nitric oxide (NO) release in BV2 microglial cells stimulated with lipopolysaccharide (LPS).
  • Evaluated effects of CS1 and CS2 on NO, tumor necrosis factor (TNF)-alpha, and prostaglandin E(2) production in primary rat microglia.
  • Analyzed mRNA expression of inflammatory mediators and activation of nuclear factor-kappaB (NF-kB) and Akt pathways.

Main Results:

  • 5-chloroacetyl-2-piperidino-1,3-selenazole (CS1) and 5-chloroacetyl-2-morpholino-1,3-selenazole (CS2) significantly inhibited LPS-induced NO release.
  • CS1 and CS2 reduced LPS-induced production of NO, TNF-alpha, and prostaglandin E(2) in primary microglia.
  • CS1 and CS2 attenuated LPS-induced mRNA expression for inducible NO synthase, TNF-alpha, interleukin-1beta, and cyclooxygenase-2.
  • CS1 and CS2 suppressed LPS-induced activation of NF-kB and Akt.

Conclusions:

  • CS1 and CS2 exhibit potent anti-inflammatory effects on activated microglia.
  • These compounds suppress key proinflammatory pathways, including NF-kB and Akt signaling.
  • CS1 and CS2 hold promise as neuroprotective agents for neurological diseases by modulating microglial activation.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...